Promise and Progress - Honors & Awards
Issue No. 2012
Honors & Awards
Date: December 20, 2011
Kimmel Cancer Center Deputy Director and leading epigenetics expert Stephen Baylin, M.D., received the American Cancer Society’s highest recognition, the Medal of Honor Award for his basic research pioneering body of work in cancer epigenetics.
Pediatric oncologist Patrick Brown, M.D., received a four-year, $720,000 grant from the American Cancer Society for his research exploring epigenetic therapies for childhood leukemia.
Kimmel Cancer Center nurse Laurie Bryant, R.N., was named a 2011 finalist for the Daily Record’s Health Care Heroes Award. She was recognized as a mentor to undergraduate students interested in medicine, medical students, interns and residents, by teaching them clinically and modeling the important role of nurses in defining problems and recommending care. She has also started one of the most successful unit-based volunteer programs at Johns Hopkins.
The Society of Neuro-Oncology honored Peter Burger, M.D., with its Lifetime Achievement Award recognizing his more than 35 years of contributions to the field of neuro-oncology.
Michael Carducci, M.D., received the Michaele Christian Oncology Development Award in honor of his contribution to the development of novel agents for cancer therapy.
Andrew Ewald, Ph.D., received the American Association of Anatomists Morphological Sciences Award and will present an award lecture at the group’s annual meeting. The award recognizes Ewald’s advances in the understanding of the cellular and molecular basis of the growth, remodeling, and cancerous transformation of epithelial tissues, cells that cover the surface of virtually every organ and structure in the body.
Kimmel Cancer Center Translational Research Director and pancreas cancer expert Elizabeth Jaffee, M.D., Ph.D., appeared on the Dr. Oz show to discuss advances in pancreas cancer research and her vaccine studies.
The Department of Defense Congressional Directed Medical Research Programs presented Robert Kurman, M.D., with a $9.5 million Ovarian Cancer Research Program Consortium Award. The Consortium is a major multi-institutional collaborative research effort aimed at identifying and characterizing early cellular changes associated with ovarian cancer.
Lana De Souza Lawrence, M.D., received the ASCO Conquer Cancer Foundation Breast Cancer Symposium Merit Award. The award, which includes a $25,000 grant, recognizes researchers’ contributions to progress against breast cancer, was given to De Souza Lawrence for her research on triple-negative breast cancer.
Robert Miller, M.D., and Julie Brahmer, M.D., were recipients of the 2011 American Society of Clinical Oncology (ASCO) Statesman Award. The award recognizes ASCO members for extraordinary volunteer service, dedication and commitment.
Barry Nelkin, Ph.D., was awarded a $1.2 million grant from the American Cancer Society for his research on the development, genetic characterization, and application of new scientific models for medullary thyroid cancer.
Kimmel Cancer Center director William Nelson, M.D., Ph.D., was one of only two investigators to receive the A. David Mazzone-Prostate Cancer Foundation Challenge Award aimed at accelerating scientific discovery and new treatments for prostate cancer. Nelson was recognized for his innovative research on the reversal of gene silencing. The award includes a 5-year, $5 million research grant.
Martin Pomper, M.D., Ph.D., was named the William R. Brody Professor of Radiology. Pomper is the inaugural recipient of this professorship, designated for a radiologist physician scientist who excels in translational innovation in imaging.
Pediatric Oncology clinician-scientist Eric Raabe, M.D., Ph.D., was named a St. Baldrick’s Pediatric Neuro-oncology Fellow receiving a three-year grant totaling $330,000 to support his work on pediatric brain tumors.
Richard Roden, Ph.D., received the V Foundation Translational Research Grant which includes a three-year, $600,000 grant. The grant is aimed at transforming basic scientific discoveries into clinical applications, such as new diagnostics and treatments.
Charles M. Rudin, M.D., Ph.D., received the 2011 Caring for Carcinoid Foundation-AACR Grants for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research. The two-year, $250,000 grant will support Rudin’s research of novel therapeutic approaches for carcinoid tumors and pancreatic neuroendocrine tumors.
Lillie Shockney, R.N., B.S., M.A.S., received the Amoena Corp. award for “Outstanding Contribution to the Breast Center Industry. Amoena Corp. is a women’s wellness company focused on helping women following breast surgery. Shockney also was inducted into the Nu Beta Chapter of the Sigma Theta Tau International Honor Society of Nursing. She was named editor-in-chief of the Journal of Oncology Navigation and Survivorship, a new journal for nurses implementing strategies in patient navigation and survivorship care.
Kimmel Cancer Center Senior Director of Development Ellen Stifler was named a member of the Senior Management Team for the Fund for Johns Hopkins Medicine.
Sara Sukumar, Ph.D., won a BioMaryland LIFE Prize, which includes a $50,000 award, for her discovery of methylated gene biomarkers that may better predict how patients whose breast cancers are estrogen receptor (ER) negative will respond to various treatments and potentially if they are at risk for future recurrences.
The National Institutes of Health Center for Scientific Review appointed Connie Trimble, M.D., to a four-year term on its Cancer Immunopathology and Immunotherapy Study Section. Trimble was selected based on her achievements in cancer immunology and will review and make recommendations on grant applications submitted to the NIH and survey the state of immunology research.
Victor Velculescu, M.D., Ph.D., received a Paul Marks Prize for Cancer Research. The award recognizes young investigators who have become leaders in cancer research through significant contributions to the understanding of cancer.
The Brupbacher Foundation in Zurach presented Bert Vogelstein, M.D., with its Charles Rodolphe Brupbacher Prize for Cancer Research. The prize is given biennially to a scientist “internationally acknowledged for meritorious achievements in the field of fundamental research.” Vogelstein was selected for his pioneering research of colon cancer development. Vogelstein also has been named one of the Johns Hopkins University’s 17 inaugural Gilman Scholars. The newly created designation, named for the University’s visionary first President Daniel Coit Gilman, recognizes individuals who are exemplars of the highest ideals of the university, demonstrated through a record of distinguished research, artistic and creative activity, teaching and service.
The V Foundation awarded Vasan Yegnasubramanian, M.D., Ph.D., its Martin D. Abeloff, M.D., Scholar Award. The award, which includes a two-year $200,000 grant, supports his research to identify DNA-based biomarkers that can help risk-stratify men with prostate cancer and aid in the clinical decision-making.